← Back to the home page
GLP-1 / Weight Management

Retatrutide 50mg

Lab-made peptide, one molecule designed around three hormone receptors.

Sold as
Box of 10 vials, 50mg each
Form
Freeze-dried (lyophilised) white powder in a sealed, unlabelled glass vial.

Apply for a trade account

Retatrutide 50mg vial, research use only

About Retatrutide

What it is

A lab-made peptide, which is a short chain of amino acids. It was developed by Eli Lilly and is built to act on three hormone receptors at once.

How it works

It switches on the receptors for three gut and pancreas hormones: GLP-1, GIP and glucagon. That is why it is called a 'triple agonist'.

What it has been studied for

  • appetite and body-weight regulation
  • blood sugar control in type 2 diabetes
  • fatty liver disease
  • knee osteoarthritis and obesity

Status

Retatrutide is investigational and not approved as a medicine anywhere: Eli Lilly reported phase 3 results in 2026 and has said it plans to file with the US FDA in early 2027, and this product is not a medicine.

Storage

Keep the sealed vial in the fridge (2-8 °C), away from light and moisture. For storage longer than a few months, keep it frozen (-20 °C). Avoid warming and cooling it over and over.

For research use only. Not a medicine, not for human or veterinary use. This page explains the compound for researchers and trade buyers; it is not medical advice.